CHCGX | RGEBX | CHCGX / RGEBX | |
Total Expense Ratio | 1.76 | 1.09 | 161% |
Annual Report Gross Expense Ratio | 1.76 | 1.09 | 161% |
Fund Existence | 28 years | 11 years | - |
Gain YTD | 2.226 | 4.829 | 46% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 42.6M | 306B | 0% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 5.98 | 7.68 | 78% |
Returns for 3 years | 39.23 | 51.01 | 77% |
Returns for 5 years | 34.06 | 45.42 | 75% |
Returns for 10 years | 116.57 | 65.87 | 177% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 32.69 | -0.22 | -0.67% |
Eventide Healthcare & Life Sciences A | |||
ABWIX | 16.24 | -0.15 | -0.92% |
AB All Market Total Return I | |||
CNPFX | 66.01 | -0.79 | -1.18% |
American Funds New Perspective 529F | |||
ECFGX | 22.66 | -0.30 | -1.31% |
Eaton Vance Focused Growth Opps C | |||
APDYX | 24.26 | -0.40 | -1.62% |
Artisan Developing World Advisor |